Crystal Structure of 6,7-Dihydro-5a,7a,13,14-tetraaza-pentaphene-5,8-dione by Guillon, Jean et al.
HAL Id: hal-02330806
https://hal-normandie-univ.archives-ouvertes.fr/hal-02330806
Submitted on 20 Jul 2020
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d’enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.
Crystal Structure of
6,7-Dihydro-5a,7a,13,14-tetraaza-pentaphene-5,8-dione
Jean Guillon, Maria de Fatima Pereira-Rosenfeld, Noël Pinaud, Thierry
Besson, Valérie Thiéry, Laurent Picot, Mathieu Marchivie
To cite this version:
Jean Guillon, Maria de Fatima Pereira-Rosenfeld, Noël Pinaud, Thierry Besson, Valérie Thiéry,
et al.. Crystal Structure of 6,7-Dihydro-5a,7a,13,14-tetraaza-pentaphene-5,8-dione. X-Ray Struc-
ture Analysis Online, Japan Society for Analytical Chemistry’s, 2019, 35 (10), pp.57-59.
￿10.2116/xraystruct.35.57￿. ￿hal-02330806￿
X-Ray Structure Analysis Online 2019, VOL. 35 57
Condensed heterocycles of quinazolines have become attractive 
targets in synthetic and medicinal chemistry due to their useful 
and significant pharmacological activities.  Thus, the occurrence 
of the quinazoline skeleton in various natural and synthetic 
products has generated the interest of many groups on account 
of its useful biological properties such as analgesic, anti-
inflammatory, anti-convulsant, sedative-hypnotic, anti-histaminic, 
anti-hypertensive, anti-cancer, anti-microbial, anti-tubercular 
and anti-viral activities.1–3  As a part of our ongoing research 
activity, we launched a research program dealing with the 
preparation and pharmacological evaluation of some original 
quinazoline derivatives structurally related to well-studied 
terrestrial alkaloids (e.g. Rutaecarpine and Luotonine A), which 
possess a quinazolin-4-one moiety fused with indolopyrido and 
pyrroloquinoline ring systems,4 respectively.  Thus, exploring 
the potential synthetic applications of the Niementowski reaction 
and in association with our work on the application of 
microwaves in organic chemistry, we planned to prepare novel 
pentacyclic tetraaza-pentaphene-5,8-diones, from various 
anthranilic acids and 2,3-condensed (3H)-quinazolin-4-ones.4  
In particular, this kind of pentacyclic fused bisquinazolinones 
has been described as being antibacterial, antifungal, 
antitubercular and antiproliferative agents.4–6
We report herein on the structural characterization of the 
6,7-dihydro-5a,7a,13,14-tetraaza-pentaphene-5,8-dione (Fig. 1), 
a fused bis-quinazolin-4-one derivative that has been synthesized 
via a modified Niementowski condensation.4  This new 
pentacyclic bisquinazolinone induced 40.2 ± 3.3% and 6.9 ± 
3.5% growth inhibition at 10 and 1 μM, respectively, which can 
be considered to be a high antiproliferative activity, in the range 
of growth inhibition obtained with control antimelanoma drugs 
(Vemurafenib, BRAF inhibitor, IC50 = 11.71 μM).
Colorless crystals having dimensions of 0.25 × 0.10 × 
0.10 mm3 suitable for X-ray diffraction analysis were obtained 
by slow crystallization from a dichloromethane–methanol 
solution at +20°C.  The molecular structure of the pentacyclic 
title compound is depicted in Fig. 2.  Crystal and experimental 
data are given in Table 1.
Crystallographic data of this pentacyclic compound were 
collected at  296 K with an Enraf–Nonius CAD-4 diffractometer 
using the Cu Kα radiation (λ = 1.5418 Å).  The collected data 
were reduced using NONIUS CAD4 software, and all reflections 
were used for unit-cell refinement.  The crystal structure was 
solved by direct methods and successive Fourier difference 
syntheses with the SHELXS program.7  Refinement of the 
crystal structure was performed on F2 by weighted anisotropic 
full-matrix least-squares methods using the SHELXL program.7  
An absorption correction was performed using the psi-scan 
method.8  All non-H atoms were refined anisotropically, and the 
positions of the H atoms were deduced from the coordinates of 
the non-H atoms to which they are linked, confirmed by Fourier 
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The X-ray crystal structure of 6,7-dihydro-5a,7a,13,14-tetraaza-pentaphene-5,8-dione, a potential antiproliferative agent 
on A2058 melanoma cells, was established.  It crystallizes in the monoclinic space group P21/c with cell parameters 
a = 24.879(3)Å, b = 6.868(2)Å, c = 26.068(4Å, α = 90, β = 110.49(2), γ = 90, V = 4172.4(15)Å3 and Z = 12.  The 
crystal structure was refined to final values of R1 = 0.1353 and wR2 = 0.1936.  An X-ray crystal structure analysis 
revealed that each molecule features intermolecular CArom.–H···O hydrogen bonds to form trimers.
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Fig. 1　Chemical structure of 6,7-dihydro-5a,7a,13,14-tetraaza-
pentaphene-5,8-dione.
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synthesis and treated according to the riding model during 
refinement.  H atoms were included for structure factor 
calculations, but not refined.  Some measured intensities 
presented unexpected bias.  Then, deviations, | Fo2–Fc2 |, do not 
follow a statistical normal distribution, which is probably due to 
unresolved twinning of the crystal.  The most affected intensities 
were thus omitted from refinement, and weights have been 
manually adjusted at the final stage to reach a goodness of fit 
close to 1.
Crystallographic data have been deposited in the Cambridge 
Crystallographic Data Centre (CCDC 267198).  Copies of these 
data can be obtained free of charge from the Director, CCDC, 
12 Union Road, Cambridge, CB2 1EZ, UK (fax: +44 1223 336 
033; e-mail: deposit@ccdc.cam.ac.uk or http://www.ccdc.cam.
ac.uk/data_request/cif.
The title compound crystallizes in the monoclinic P21/c space 
group, and the asymmetric unit is constituted by three 
independent molecules of 6,7-dihydro-5a,7a,13,14-tetraaza-
pentaphene-5,8-dione (designated as A, B and C).  The three 
indepandent molecules develop intermolecular CArom.–H···O 
hydrogen bonds to form supramolecular trimers (Fig. 2).  In the 
title compound, all bond lengths and angles of the fused 
heterocyclic rings were found to be within the normal ranges by 
comparing with the earlier substituted fused quinazolin-4-one 
derivatives.4,9
X-ray data confirmed the pentacyclic 6,7-dihydro-5a,7a,13,14-
tetraaza-pentaphene-5,8-dione structure in the solid state.  The 
C1a–N1a, C18a–N4a, C1b–N1b, C18b–N4b, C1c–N1c, C18c–
N4c bonds in this bis-quinazolin-4-one derivative were found in 
the range of 1.293(5) to 1.318(5)Å, as typically observed for the 
C=N double bonds,10 while the various C–N single bonds were 
noticed at 1.379(5) – 1.488(5)Å.  The various quinazolinone 
systems of the title compound were also found to be quite planar 
with a maximum displacement from the mean plane of 0.067(3)Å 
for N3a.  The interplanar dihedral angles between the quinazolinone 
least-squares planes in each independent molecule were found 
at 18.15(8), 21.02(7) and 20.69(7) for molecules A, B and C 
respectively.  In addition, the torsion angles of the conjugated 
N1–C1–C18–N4, were observed at 19.9(6), 22.7(5) and 21.5(6)°, 
for molecule A, B and C respectively.  Moreover, the torsion 
angle N2–C9–C10–N3 was found at 58.4(4)° for A, and their 
homologous torsion angles were noticed in the same range at 
60.7(4)° and 61.7(5)°, for B and C respectively.  The C=O bonds 
were noticed in the range of 1.222(5) to 1.231(5)Å, as typically 
observed for Csp2=O bonds in lactams.
The crystal-structure cohesion is then ensured by several 
H-bond like interactions between the carbonyl and aromatic 
hydrogen that form trimers that are linked together by weaker 
H-bond like interactions (Table S1) within approximately the a 
direction and by and π-stacking within the b direction (Table S2 
and Fig. S1).  Weaker Van der Waals contacts complete the 
intermolecular interactions in the crystal structure approximately 
in the c direction.
Supporting Information
A CIF format file and Tables S1 and S2, and Fig. S1.  These 
materials are available free of charge on the Web at http://www.
jsac.or.jp/xraystruct/.
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